Company intelligence / Profile preview

Biomedical Investments

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

Biomedical Investments (1997) Ltd. was a prominent Israeli venture capital and investment firm focused exclusively on the life sciences, biotechnology, and medical device sectors. Founded in 1997, the company specialized in identifying and funding early-to-mid-stage healthcare innovations within the Israeli ecosystem, often partnering with major pharmaceutical players like Teva Pharmaceutical Industries. The firm maintained a diverse portfolio of companies working on advanced therapeutics and medical technologies before being acquired by Clal Biotechnology Industries (CBI) in 2010. Its operations were instrumental in the early growth of several Israeli biotech success stories through strategic capital and hands-on management.

Industry: Investors

Partnerships

Teva Pharmaceutical Industries

Beyond the preview

Go deeper on Biomedical Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedical Investments.

Explore the full profile